We are looking for technical, scientific presentations from speakers who can share data and lessons learned from their oligonucleotide, peptide, mRNA, genome editing and drug delivery programs. Case studies of preclinical, clinical and CMC projects are highly desired.
We are looking for presentations in the following topic areas:
- AI & Machine Learning in Oligo/Peptide Drug Design/Development
- Oligo/Peptide/mRNA/Genome Editing Discovery or Clinical: Case Studies
- Peptide Macrocycles, Screening Tools, Combinatorial Peptides, Difficult Targets
- Oligonucleotide Medicinal Chemistry & Chemistry Strategies
- Oligonucleotides for CNS Diseases
- Oligo/Peptide CMC Case Studies: Efficiencies, Scale-up, New Modalities, Cost Savings
- Sustainable Manufacturing: Continuous Processing and Green Chemistry
- Oligonucleotide Analytics
- Emerging Approaches to Enzymatic Synthesis for DNA and RNA
- GLP-1 & Beyond: Peptide Therapeutics for Diabetes and Obesity
- Translational Strategies to Accelerate Peptides to the Clinic
- Targeted Peptide Radiopharmaceuticals
- Delivery of Peptides OR Peptides as Delivery Vehicles OR Peptide-Conjugates
- mRNA Progress (non-COVID): Discovery to Clinic OR mRNA Manufacturing
- Genome Editing (CRISPR, Base, Prime): Discovery to Clinic, Delivery or CMC
- Next-Gen Delivery & Innovation for Oligos, Peptides, mRNA, Genome Editing
- Novel Oligo Delivery: Beyond LNP, Non-Viral, Extra-Hepatic, BBB Approaches
- In Vivo CAR-T & In Vivo Genome Editing Progress and Case Studies
- Non-traditional RNA Therapeutic Strategies (RNA 2.0)
Tuesday, May 10, 2016
3:00 pm - 6:30 pm
Wednesday, May 11, 2016
10:00 am - 6:30 pm
Thursday, May 12, 2016
10:30 am - 2:00 pm
Presentations should be free of commercial bias as well as any references to commercial products and services. All selected faculty are required to disclose the existence of any significant financial interest. Financial interest may affect the consideration of your presentation/proposal application.
PLEASE FILL OUT FORM BELOW IF INTERESTED IN SPEAKING: